These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
178 related articles for article (PubMed ID: 12651258)
21. [Stem cell transplantations as a treatment of severe autoimmune diseases]. Jantunen E; Myllykangas-Luosujärvi R; Kaipiainen-Seppänen O; Mahlamäki E; Nousiainen T Duodecim; 2000; 116(7):721-7. PubMed ID: 12078138 [No Abstract] [Full Text] [Related]
22. Intense immunosuppression followed by autologous haematopoietic stem cell transplantation as a therapeutic strategy in aggressive forms of multiple sclerosis. Mancardi G; Sormani MP; Muraro PA; Boffa G; Saccardi R Mult Scler; 2018 Mar; 24(3):245-255. PubMed ID: 29125439 [TBL] [Abstract][Full Text] [Related]
29. Autologous hematopoietic stem cell transplantation for type 1 diabetes. Voltarelli JC; Couri CE; Stracieri AB; Oliveira MC; Moraes DA; Pieroni F; Barros GM; Madeira MI; Malmegrim KC; Foss-Freitas MC; Simões BP; Foss MC; Squiers E; Burt RK Ann N Y Acad Sci; 2008 Dec; 1150():220-9. PubMed ID: 19120300 [TBL] [Abstract][Full Text] [Related]
30. The long-term effect of AHSCT on MRI measures of MS evolution: a five-year follow-up study. Roccatagliata L; Rocca M; Valsasina P; Bonzano L; Sormani M; Saccardi R; Mancardi G; Filippi M; Mult Scler; 2007 Sep; 13(8):1068-70. PubMed ID: 17468445 [TBL] [Abstract][Full Text] [Related]
32. Allogeneic hematopoietic stem cell transplantation in a patient affected by large granular lymphocyte leukemia and multiple sclerosis. La Nasa G; Littera R; Cocco E; Battistini L; Marrosu MG; Contu L Ann Hematol; 2004 Jun; 83(6):403-5. PubMed ID: 14648027 [TBL] [Abstract][Full Text] [Related]
38. Autologous hematopoietic stem cell transplantation for pediatric solid tumors. Hale GA Expert Rev Anticancer Ther; 2005 Oct; 5(5):835-46. PubMed ID: 16221053 [TBL] [Abstract][Full Text] [Related]
39. Immunological reconstitution after autologous hematopoietic stem cell transplantation in patients with systemic sclerosis: relationship between clinical benefits and intensity of immunosuppression. Bohgaki T; Atsumi T; Bohgaki M; Furusaki A; Kondo M; Sato-Matsumura KC; Abe R; Kataoka H; Horita T; Yasuda S; Amasaki Y; Nishio M; Sawada K; Shimizu H; Koike T J Rheumatol; 2009 Jun; 36(6):1240-8. PubMed ID: 19447934 [TBL] [Abstract][Full Text] [Related]
40. Normal bone marrow hematopoietic stem cell reserves and normal stromal cell function support the use of autologous stem cell transplantation in patients with multiple sclerosis. Papadaki HA; Tsagournisakis M; Mastorodemos V; Pontikoglou C; Damianaki A; Pyrovolaki K; Stamatopoulos K; Fassas A; Plaitakis A; Eliopoulos GD Bone Marrow Transplant; 2005 Dec; 36(12):1053-63. PubMed ID: 16205726 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]